Welcome to our dedicated page for Marqeta SEC filings (Ticker: MQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Marqeta, Inc. discloses operating results and governance changes through SEC filings tied to its modern card issuing platform. Recent Form 8-K reports furnish quarterly and annual earnings releases, including Total Processing Volume, net revenue, gross profit, GAAP results and Adjusted EBITDA.
The filing record also documents leadership and officer-designation matters, including executive appointments, principal financial and accounting officer roles, compensation arrangements and equity awards. Definitive proxy materials cover board matters, executive compensation, shareholder voting items and related corporate-governance disclosures.
Marqeta director Najuma Atkinson reported an open-market sale of 10,889 shares of Class A Common Stock at a weighted average price of $3.7979 per share. According to the footnote, the shares were sold in multiple trades between $3.73 and $3.88. After this transaction, Atkinson directly holds 178,417.218 shares.
Marqeta, Inc. director Martha Cummings reported an open-market sale of 14,831 shares of Class A Common Stock on June 12, 2026 at a weighted average price of $3.7983 per share. After this transaction, she directly holds 51,876 shares.
Marqeta, Inc. director Elaine Paul reported an open-market sale of 18,148 shares of Class A Common Stock on June 12, 2026 at a weighted average price of $3.7969 per share. After this transaction, Paul directly holds 35,602 Marqeta shares. The sale was executed in multiple trades at prices ranging from $3.72 to $3.88 per share.
Marqeta, Inc. director Alpesh Chokshi exercised restricted stock units, receiving 25,592 shares of Class A Common Stock at a stated price of $0.00 per share. Following the transaction, he directly holds 87,482 Class A shares. The underlying RSU award vests in three equal installments on June 13, 2025, June 13, 2026, and June 13, 2027, contingent on continued service.
Marqeta, Inc. officer Crystal Sumner reported an open-market sale of 5,056 shares of Class A Common Stock. The shares were sold at a weighted average price of $3.8877 per share, with individual trade prices ranging from $3.85 to $3.92.
After this transaction, Sumner directly holds 594,926 shares of Marqeta Class A Common Stock. This filing reflects a relatively small sale compared with the remaining reported holdings.
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice reporting proposed sales of Common stock tied to Restricted Stock Units. The filing lists 10,889 shares associated with the issuer designation and an earlier 10b5-1 sale by Najuma Atkinson of 9,259 shares on 04/20/2026.
Form 144 notice to sell 18,148 shares of Common Stock — a Form 144 filing lists 18,148 shares of Common Stock (Restricted Stock Units) to be sold on 06/12/2026. The filing shows prior 10b5-1 sales of 17,452 shares on 04/21/2026 by Laura Elaine Paul. The broker listed is Morgan Stanley Smith Barney LLC. The filing is a resale notice under Rule 144 and does not itself report completion of the proposed sale.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting proposed sales of Common stock tied to Restricted Stock Units. The filing lists 20,536 shares with an intended sale date of 06/12/2025 and records three 10b5-1 sales of 2,853 shares each on 03/16/2026, 04/15/2026, and 05/15/2026.
Marqeta director Martha Cummings reported routine equity compensation activity. She exercised 36,297 restricted stock units into the same number of Class A Common shares, bringing her direct Class A holdings to 66,707 shares. She also received a new grant of 52,219 restricted stock units that each convert into one Class A share and vest in full on the earlier of June 10, 2027 or Marqeta’s next annual stockholder meeting, subject to continued service.
Marqeta, Inc. director Prasad Srikiran reported equity compensation-related transactions in Class A Common Stock and Restricted Stock Units. He exercised derivative securities covering 36,297 shares of Class A Common Stock, bringing his direct holdings in the stock to 162,634 shares following the transaction.
He also received a grant of 52,219 Restricted Stock Units, each convertible into one share of Class A Common Stock. According to the grant terms, all of these RSUs vest in full on the earlier of June 10, 2027 or the company’s next annual meeting of stockholders, subject to continued service.
Footnotes state that the exercise is exempt from Section 16(b) under Rule 16b-6(b) and that a prior RSU grant made on June 12, 2025 vested in full on June 10, 2026, aligning with annual meeting dates. The filing reflects routine director equity awards and vesting rather than open-market buying or selling.